Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Budesonide Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Budesonide Market Status and Forecast (2016-2027)
      • 1.3.2 Global Budesonide Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Budesonide Supply by Company

    • 2.1 Global Budesonide Sales Volume by Company
    • 2.2 Global Budesonide Sales Value by Company
    • 2.3 Global Budesonide Price by Company
    • 2.4 Budesonide Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Budesonide Market Status by Category

    • 3.1 Budesonide Category Introduction
      • 3.1.1 Injectable Suspension
      • 3.1.2 Aerosols
      • 3.1.3 Inhalation Powder
      • 3.1.4 Tablet and Capsule
    • 3.2 Global Budesonide Market by Category
      • 3.2.1 Global Budesonide Sales Volume by Category (2016-2021)
      • 3.2.2 Global Budesonide Sales Value by Category (2016-2021)
      • 3.2.3 Global Budesonide Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Budesonide Market Status by End User/Segment

    • 4.1 Budesonide Segment by End User/Segment
      • 4.1.1 Respiratory Disease Treatment
      • 4.1.2 Nose Disease Treatment
    • 4.2 Global Budesonide Market by End User/Segment
      • 4.2.1 Global Budesonide Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Budesonide Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Budesonide Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Budesonide Market Status by Region

    • 5.1 Global Budesonide Market by Region
      • 5.1.1 Global Budesonide Sales Volume by Region
      • 5.1.2 Global Budesonide Sales Value by Region
    • 5.2 North America Budesonide Market Status
    • 5.3 Europe Budesonide Market Status
    • 5.4 Asia Pacific Budesonide Market Status
    • 5.5 Central & South America Budesonide Market Status
    • 5.6 Middle East & Africa Budesonide Market Status

    6 North America Budesonide Market Status

    • 6.1 North America Budesonide Market by Country
      • 6.1.1 North America Budesonide Sales Volume by Country (2016-2021)
      • 6.1.2 North America Budesonide Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Budesonide Market Status

    • 7.1 Europe Budesonide Market by Country
      • 7.1.1 Europe Budesonide Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Budesonide Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Budesonide Market Status

    • 8.1 Asia Pacific Budesonide Market by Country
      • 8.1.1 Asia Pacific Budesonide Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Budesonide Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Budesonide Market Status

    • 9.1 Central & South America Budesonide Market by Country
      • 9.1.1 Central & South America Budesonide Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Budesonide Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Budesonide Market Status

    • 10.1 Middle East & Africa Budesonide Market by Country
      • 10.1.1 Middle East & Africa Budesonide Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Budesonide Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Budesonide Distributors
    • 11.3 Budesonide Buyers

    12 Global Budesonide Market Forecast by Category and by End User/Segment

    • 12.1 Global Budesonide Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Budesonide Forecast by Category
      • 12.2.1 Global Budesonide Sales Volume Forecast by Category
      • 12.2.2 Global Budesonide Sales Value Forecast by Category
      • 12.2.3 Global Budesonide Price Forecast by Category
    • 12.3 Global Budesonide Forecast by End User/Segment
      • 12.3.1 Global Budesonide Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Budesonide Sales Value Forecast by End User/Segment
      • 12.3.3 Global Budesonide Price Forecast by End User/Segment

    13 Global Budesonide Market Forecast by Region/Country

    • 13.1 Global Budesonide Market Forecast by Region (2022-2027)
      • 13.1.1 Global Budesonide Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Budesonide Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 AstraZeneca
      • 14.1.1 Company Information
      • 14.1.2 Budesonide Product Introduction
      • 14.1.3 AstraZeneca Budesonide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Teva
      • 14.2.1 Company Information
      • 14.2.2 Budesonide Product Introduction
      • 14.2.3 Teva Budesonide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Mylan
      • 14.3.1 Company Information
      • 14.3.2 Budesonide Product Introduction
      • 14.3.3 Mylan Budesonide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Sandoz
      • 14.4.1 Company Information
      • 14.4.2 Budesonide Product Introduction
      • 14.4.3 Sandoz Budesonide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Cosmo Pharmaceuticals
      • 14.5.1 Company Information
      • 14.5.2 Budesonide Product Introduction
      • 14.5.3 Cosmo Pharmaceuticals Budesonide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 Salix
      • 14.6.1 Company Information
      • 14.6.2 Budesonide Product Introduction
      • 14.6.3 Salix Budesonide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Chiesi Farmaceutici
      • 14.7.1 Company Information
      • 14.7.2 Budesonide Product Introduction
      • 14.7.3 Chiesi Farmaceutici Budesonide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Orion Corporation
      • 14.8.1 Company Information
      • 14.8.2 Budesonide Product Introduction
      • 14.8.3 Orion Corporation Budesonide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 Cipla
      • 14.9.1 Company Information
      • 14.9.2 Budesonide Product Introduction
      • 14.9.3 Cipla Budesonide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 Synmosa Biopharma
      • 14.10.1 Company Information
      • 14.10.2 Budesonide Product Introduction
      • 14.10.3 Synmosa Biopharma Budesonide Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 Lunan Better Pharma
    • 14.12 Shanghai Sine Promod

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Budesonide market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Budesonide market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Injectable Suspension
    Aerosols
    Inhalation Powder
    Tablet and Capsule

    Segmented by End User/Segment
    Respiratory Disease Treatment
    Nose Disease Treatment

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    AstraZeneca
    Teva
    Mylan
    Sandoz
    Cosmo Pharmaceuticals
    Salix
    Chiesi Farmaceutici
    Orion Corporation
    Cipla
    Synmosa Biopharma
    Lunan Better Pharma
    Shanghai Sine Promod
    Buy now